EYPT
EyePoint Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Jay S. Duker
IPO Date
2005-01-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
EyePoint Pharmaceuticals, Inc.
CEO
Jay S. Duker
IPO Date
2005-01-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 3,627 |
| $12.93 |
| 27 May 2026 | Elston George | Chief Financial Officer | M-Exempt | Disposed | 7,500 | $0.00 |
| 20 Apr 2026 | Ribeiro Ramiro | Chief Medical Officer | M-Exempt | Acquired | 2,437 | $8.26 |
| 20 Apr 2026 | Ribeiro Ramiro | Chief Medical Officer | S-Sale | Disposed | 2,437 | $15.00 |
| 20 Apr 2026 | Ribeiro Ramiro | Chief Medical Officer | M-Exempt | Disposed | 2,437 | $8.26 |
| 24 Mar 2026 | Duker Jay S. | director, officer: President and CEO | J-Other | Disposed | 76,766 | $13.11 |
| 24 Mar 2026 | Duker Jay S. | director, officer: President and CEO | J-Other | Acquired | 76,766 | $13.11 |
| 24 Mar 2026 | Duker Jay S. | director, officer: President and CEO | J-Other | Disposed | 52,500 | $13.13 |
| 24 Mar 2026 | Duker Jay S. | director, officer: President and CEO | J-Other | Acquired | 52,500 | $13.13 |